Efficacy and safety of pramipexole in restless legs syndrome

2008 ◽  
Vol 2008 ◽  
pp. 80
Author(s):  
S. Papapetropoulos
2021 ◽  
Vol 12 ◽  
Author(s):  
Hyoeun Bae ◽  
Yong Won Cho ◽  
Keun Tae Kim ◽  
Richard P. Allen ◽  
Christopher J. Earley

Pregabalin is increasingly being used as a first-line treatment for symptomatic control of restless legs syndrome (RLS). This study aimed to evaluate the efficacy and safety of pregabalin as add-on therapy in RLS patients already taking dopamine agonists (DA) but still in need of further management. Patients with idiopathic RLS were enrolled, and all had already been prescribed DA for at least 3 months but still had either persistent symptoms, side effects, or comorbid insomnia. An initial dose of 75 mg pregabalin was begun, adjusted as needed, and maintained at a stable dose for 4 weeks, followed by observation for a total of 8 weeks. RLS symptoms and insomnia scores were evaluated before and after add-on pregabalin treatment. Patients were monitored for side effects that could be attributed to pregabalin. A total of 32 RLS patients were enrolled, and 20 subjects remained until the endpoint. After the pregabalin add-on, the mean IRLS score showed significant improvement compared to the baseline (p < 0.001). The insomnia severity index score also improved (p = 0.036), and no serious adverse effects were observed. Our preliminary data suggests the potential for pregabalin as an add-on therapy to DA with regards to both efficacy and safety in patients who have inadequate RLS improvement.


2015 ◽  
Vol 16 (11) ◽  
pp. 1342-1347 ◽  
Author(s):  
Juliane Schneider ◽  
Alexander Krafft ◽  
Mauro Manconi ◽  
Astrid Hübner ◽  
Christian Baumann ◽  
...  

Author(s):  
Yuichi Inoue ◽  
Naohisa Uchimura ◽  
Kenji Kuroda ◽  
Koichi Hirata ◽  
Nobutaka Hattori

2020 ◽  
Vol 11 ◽  
pp. 215013272090595
Author(s):  
Marjan Jahani Kondori ◽  
Bhanu Prakash Kolla ◽  
Katherine M. Moore ◽  
Meghna P. Mansukhani

Restless legs syndrome (RLS) affects about 20% of all pregnant women. RLS symptoms are usually moderate to severe in intensity during pregnancy and can result in insomnia, depression, and other adverse outcomes. Although iron deficiency has been implicated as a potential etiological factor, other mechanisms can also play a role. Nonpharmacologic methods are the primary recommended form of treatment for RLS in pregnancy and lactation. Iron supplementation may be considered when the serum ferritin is low; however, several patients are unable to tolerate iron or have severe symptoms despite oral iron replacement. Here, we describe a case of severe RLS in pregnancy and illustrate the dilemmas in diagnosis and management. We review the literature on the prevalence, diagnosis, course, possible underlying pathophysiologic mechanisms and complications of RLS in pregnancy. We describe current best evidence on the efficacy, and safety of nonpharmacologic therapies, oral and intravenous iron supplementation, as well as other medication treatments for RLS in pregnancy and lactation. We highlight gaps in the literature and provide a practical guide for the clinical management of RLS in pregnancy and during breastfeeding.


Neurology ◽  
2007 ◽  
Vol 68 (19) ◽  
pp. 1641-1642 ◽  
Author(s):  
S. P. Kruszewski ◽  
J. Shane ◽  
J .W. Winkelman ◽  
K .D. Sethi ◽  
C .A. Kushida ◽  
...  

2012 ◽  
Vol 13 (3) ◽  
pp. 228-236 ◽  
Author(s):  
Magdolna Hornyak ◽  
Claudia Trenkwalder ◽  
Ralf Kohnen ◽  
Hanna Scholz

2006 ◽  
Vol 7 (5) ◽  
pp. 407-417 ◽  
Author(s):  
Markku Partinen ◽  
Kari Hirvonen ◽  
Leni Jama ◽  
Anniina Alakuijala ◽  
Christer Hublin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document